-
Product Insights
Los Pradillos Toledo Solar PV Park
Los Pradillos Solar PV Project is a solar PV project located in Spain. The project is owned by Smartenergy Invest AG and is developed by Greenfield PV SL; Prodiel Proyectos de Instalaciones Electricas SL. The project is at the permitting stage. Empower your strategies with our Los Pradillos Solar PV Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business...
-
Product Insights
Inferior Vena Cava Filters (IVCF) Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
IVCF Pipeline Market Report Overview An Inferior Vena Cava Filter (IVCF) is a metallic device used to prevent blood clots from traveling to the lungs. The filter is inserted inside a large vein called the inferior vena cava that carries blood from the lower extremities to the heart. IVC is commonly used as a preventive measure in cases where DVT and PE have been diagnosed or as a prophylactic device in cases where the risk of developing VTE is high...
-
Product Insights
Georgia Pacific Toledo Mill Biomass Power Project
Georgia Pacific Toledo Mill Biomass Power Project is a biopower project located in Oregon, United States. The project came online in 2007. Empower your strategies with our Georgia Pacific Toledo Mill Biomass Power Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or...
-
Product Insights
Therma Visayas Toledo Coal Fired Power Plant
Therma Visayas Toledo Coal Fired Power Plant is a thermal project located in Central Visayas, Philippines. The project is owned by Aboitiz Equity Ventures Inc; JERA Co Inc and others; PCD Nominee Corp; Vivant Energy Corp and was developed by Therma Power Visayas, Inc.. The project came online in 2019. Empower your strategies with our Therma Visayas Toledo Coal Fired Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon...
-
Product Insights
Clot Management Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Clot Management Devices Pipeline Market Report Overview Clot Management Devices are used for the removal or dissolution of a clot from a blood vessel to restore proper blood circulation. This device is used as a routine procedure while performing percutaneous coronary intervention and for treating potentially life-threatening complications. The clot management devices pipeline market research report provides comprehensive information on the products with their comparative segment-wise analysis in various stages of development. The report also covers the regional and country-wise...
-
Company Insights
Innovation and Patenting activity of Mettler-Toledo International Inc Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Mettler-Toledo International Inc Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
NewRaynauds Disease – Drugs In Development, 2024
Empower your strategies with our Raynauds Disease – Drugs In Development, 2024 report and make more profitable business decisions. Raynauds disease is a common condition that affects the blood supply to certain parts of the body, usually the fingers and toes. Predisposing factors include age, gender, family history, and smoking. Symptoms include fingers, toes, ears, or nose turning white and then blue. Treatment includes vasodilators, alpha blockers, and calcium channel blockers. The Raynauds Disease drugs in development market research report provide...
-
Product Insights
NewT-Cell Leukemia – Drugs In Development, 2024
Empower your strategies with our T-Cell Leukemia – Drugs In Development, 2024 report and make more profitable business decisions. T-cell leukemia is a rare type of blood cancer that affects T cells, which are white blood cells that help your body fight infection or illness. There are different types of T-cell leukemia, such as large granular lymphocytic leukemia, adult T-cell leukemia/lymphoma, and T-cell prolymphocytic leukemia. These types vary in their symptoms, risk factors, diagnosis, treatment and outlook. T-cell leukemia can be...
-
Product Insights
NewIschemia Reperfusion Injury – Drugs In Development, 2024
Empower your strategies with our Ischemia Reperfusion Injury – Drugs In Development, 2024 report and make more profitable business decisions. Ischemic reperfusion injury is the tissue damage that happens when blood supply returns to the tissue after a period of lack of oxygen. The absence of oxygen and nutrients creates a condition in which the restoration of circulation results in inflammation and oxidative damage through the induction of oxidative stress. Symptoms include headache, bradycardia, seizures and hypertension. Risk factors include hypertension,...
-
Product Insights
NewStreptococcal Pneumonia – Drugs In Development, 2024
Empower your strategies with our Streptococcal Pneumonia – Drugs In Development, 2024 report and make more profitable business decisions. Streptococcus pneumoniae, or pneumococcus, is a Gram-positive spherical bacteria, and alpha-hemolytic member of the genus Streptococcus. Pneumococcal infections are present throughout the world and are most common during the winter and early spring months. Pneumoniae is prevalent in large part due to its colonizing ability in the nasopharynx. Almost 40-50% healthy children and 20-30% of healthy adults are carriers. With childhood conjugate...